A Resolution urging the Congress of the United States to establish policies that would provide greater access to blood transfusions for hospice patients with blood cancer.

This Pennsylvania House Resolution (HR 76) urges the U.S. Congress to change Medicare reimbursement policies to cover blood transfusions for hospice patients with blood cancer. It highlights that current Medicare pays hospices a fixed daily rate ($34,465.34 annually per patient), which fails to cover the average $2,388 cost per red blood cell unit transfusion - needed twice weekly by most patients. The resolution states this reimbursement gap prevents access to palliative transfusions (used for comfort, not cancer treatment), leading patients to avoid hospice care. It specifically references a 2023 federal bill proposal that aimed to create a separate payment model for transfusions. The resolution has no legal effect but seeks to prompt federal policy changes.